United States: Preview Of Medicare Advantage And Part D Advance Notice And Call Letter: CMS Likely To Address Risk Adjustment, Provider Network, And Other Issues

The federal government will soon kick off the all-important annual sub-regulatory cycle for the Medicare Advantage (MA) and Part D programs, issuing proposed policy changes and payment rates for calendar year (CY) 2017. The proposed guidance—expected to be issued on February 19—is likely to include substantial proposed changes to the MA risk adjustment methodology and may address increased provider network oversight for MA Organizations (MAOs), among other topics.

Key topics that the Centers for Medicare & Medicaid Services (CMS) is expected to address in the document—known as CY 2017 Advance Notice and Draft Call Letter—include the following:

  • Payment Rates:  CMS's early preview of CY 2017 ratebook growth rates projected that the United States Per Capita Cost (USPCC) for Medicare Fee-for-Service beneficiaries, a measurement of year-over-year spending in the Original Medicare Program, would increase by 3.1 percent in 2017. CMS uses the USPCC to calculate MA Program benchmarks, so an increase in this measure could potentially result in increased payments to MAOs. Other factors contribute to MA payment rates, however, and CMS has in the past issued proposed growth rates in February that are significantly different from the December projections.
  • Risk Adjustment: CMS is likely to address multiple issues related to the much debated and closely watched MA risk adjustment payment methodology:
  • CMS may finalize changes to the CMS-HCC risk adjustment model originally proposed in October 2015. The changes, which CMS says are intended to increase the predictive power of the CMS-HCC risk adjustment model, may include separating the community segment of the model into six populations: full benefit dual aged, full benefit dual disabled, partial benefit dual aged, partial benefit dual disabled, non-dual aged, and non-dual disabled. According to CMS, these changes were proposed in response to concerns that the CMS-HCC risk adjustment model does not accurately predict costs for dual eligible beneficiaries and other specific beneficiary populations. In its proposal, CMS stated its intentions to include these changes in the Advance Notice.
  • CMS may once again address whether MAOs may use diagnoses collected during risk assessments for risk adjustment purposes. Although CMS has repeatedly  discussed excluding such diagnoses unless they are confirmed by a subsequent clinical encounter, the Agency has stopped short of finalizing this change. A recent Medicare Payment Advisory Commission (MedPAC) recommendation echoed CMS's earlier proposal, and CMS may revive this issue in the Advance Notice.
  • Provider Network Oversight:  The CY 2017 Draft Call Letter may also address provider network adequacy, which has received increasing attention in recent years. CMS has historically assessed MAO compliance with regulatory provider network adequacy standards only when an organization initially applies to be an MAO, or to expand its plans or service areas. Following a recent Government Accountability Office (GAO) report, CMS has recently moved to monitor network adequacy more regularly, piloting a new Program Audit module that assesses MAO compliance with network adequacy requirements and releasing a "Network Management Module" in the Health Plan Management System (HPMS) that both CMS and individual MAOs can use to evaluate provider network adequacy outside of the application process. CMS has already indicated that it will use the Network Management Module to review network adequacy of Provider Specific Plans this spring, and CMS may provide further guidance on its intended use of the Network Management Module in the CY 2017 Draft Call Letter.
  • Provider Directories: Over the past several years, CMS has expressed concerns about the accuracy of MA and Part D provider and pharmacy directories. In the revised Medicare Marketing Guidelines issued in July 2015, CMS implemented new requirements for collecting updated contact information from providers and implementing timely updates to online provider directories. In the CY 2016 Call Letter, CMS floated the possibility of a national standardized provider database that would include not only MA and Part D Plans but also Qualified Health Plans offered on the Federally Facilitated Marketplace. Data interoperability remains a challenge for efforts to streamline provider and pharmacy directories. CMS may propose additional requirements in the CY 2017 Call Letter.
  • Additional Clarity on the CY 2017 Star Ratings: We expect CMS to discuss its proposed changes to the CY 2017 Star Ratings, originally issued in a Request for Comments on November 12, 2015. Among the more significant proposed changes is the development of an interim adjustment to ensure that the Star Ratings accurately adjust for the effects of enrolling a disproportionate number of enrollees who are dual eligibles (DEs), receive a low income subsidy (LIS) and/or are disabled. Specifically, CMS proposed two interim measures: (1) a Categorical Adjustment Index, which would impact a contract's overall rating, or (2) an Indirect Standardization adjustment, which would impact scores on a particular metric. This recent proposal follows several years of studies and analysis, which CMS has concluded provide "scientific evidence that there exists a within-contract LIS/DE/disability effect for a subset of the Star Ratings measures." Although CMS presented information about the potential interim measures on December 3, 2015, the Agency has not provided significant detail about the proposals or an impact analysis as to their effect on stakeholders.
  • Expansion of the Recovery Audit Contractor Program: Although Recovery Audit Contractors (RACs) have been operating in the Original Medicare Program for years, CMS recently proposed to expand the use of RACs to the MA Program. Specifically, in a Request for Information issued December 22, 2015, CMS proposed that RACs would conduct risk adjustment data validation (RADV) audits to identify overpayments and underpayments made to MA Organizations. The RACs would conduct both comprehensive and condition-specific RADV audits to identify errors and omissions in the diagnosis data submitted to CMS. Comments were due to CMS on February 1, 2016, leaving it unclear as to whether the Agency will have any further developments to propose in the Advance Notice.
  • Meaningful Difference Evaluation: Pursuant to a policy first articulated by CMS in 2006, MAOs are only permitted to offer multiple plan offerings in a service area if they are "meaningfully different." CMS has indicated in the past that it may begin applying the meaningful difference evaluation at the legal entity/MAO level and/or the parent organization level rather than the contract level, as the evaluation is currently performed.  CMS did not finalize this change for CY 2016, but indicated that it may institute this and/or other changes to the meaningful difference evaluation in CY 2017.
  • Total Beneficiary Cost: Based on proposals identified in the CY 2016 Draft Call Letter, CMS may institute, for CY 2017, a Total Beneficiary Cost (TBC) measure for Prescription Drug Plans, similar to what has been in place for MA Plans for years, and may announce a change in the methodology for calculating the MA TBC. 
  • Opioid POS Edits: In the CY 2016 Draft Call Letter, CMS stated its expectation that Part D Plan Sponsors develop and implement a soft point-of-sale (POS) edit to prevent opioid overutilization. Based on concerns raised by stakeholders, CMS opted to delay the recommendation, although the Agency did encourage Part D Plan Sponsors to implement the recommended soft POS edit and to prepare for other POS edits that may be required in the future. Many stakeholders believe that opioid overutilization could be better addressed by allowing Part D Plan Sponsors to "lock in" Medicare beneficiaries taking certain drugs to specific prescribers and pharmacies. Such a provision, however, is not likely to be addressed in the Draft Call Letter, as it may require additional authority from Congress.
  • More Time to Comment in CY 2018: Historically, CMS has issued the annual Advance Notice and Draft Call Letter as draft sub-regulatory guidance subject to a two-week comment period. Industry stakeholders have long expressed concerns with this abbreviated timeframe for public comment. A new law enacted on December 18, 2015 will require CMS to release the Advance Notice at least 60 days prior to finalizing payment rates and provide the public with no less than 30 days to comment on the proposals. The Advance Notice may address the revised sub-regulatory timeline for CY 2018, which will likely involve an early February release of the Advance Notice in light of statutory deadlines.

Despite our projections about some of the key areas CMS may address in the Advance Notice and Draft Call Letter, a myriad of other topics will be addressed and there will likely be a few surprises. With the luxury of a four-week comment period still a year away, stakeholders will need to move quickly to analyze proposals that impact plan finances or operations, and determine whether to submit comments.

Preview Of Medicare Advantage And Part D Advance Notice And Call Letter: CMS Likely To Address Risk Adjustment, Provider Network, And Other Issues

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.